Le Lézard
Classified in: Health, Covid-19 virus
Subjects: HSP, BFA, BLK, AVO, DEI

Multicultural Healthcare Marketing Group CEO Calls on Cities and States to Establish Effective COVID-19 Vaccine Outreach in Communities of Color


NEW YORK, April 30, 2021 /PRNewswire/ -- As the nation observation of, National Minority Health Month (NMHM) ends, CEO of Multicultural Healthcare Marketing Group, Sheila Thorne, has issued a call for city, states, and healthcare organizations to 'roll up their sleeves and roll out an effective vaccine outreach in communities of color.'

In 2002, the U.S. Congress declared that a National Minority Health Month should be established to focus on the disproportionate impact of disease, disability, and premature death in people of color in America. As a leading expert on multicultural healthcare marketing, Thorne was a member of the Task Force, led by Dr. David Satcher, the 16th United States Surgeon General, that drafted the resolution and was able to get April designated as National Minority Health Month and documented in the Congressional Record.

A recent report from KFF states that the Center for Disease Control (CDC) reported that race/ethnicity was known for just over half (55%) of people who had received at least one dose of the vaccine. Among this group, nearly two-thirds were White (64%), 12% were Hispanic, 9% were Black, 6% were Asian, 1% were American Indian or Alaska Native, and <1% were Native Hawaiian or Other Pacific Islander, while 8% reported multiple or other race.  Thorne's appeal comes amidst these staggering statistics and in the wake of President Joe Bidens' announcement to move the deadline for adult eligibility for Covid-19 vaccines from May 1 to April 19.

For 30 years, Sheila Thorne has played an instrumental role in increasing the understanding of cultural insights and ethnically diverse communities of color with organizations and health care systems.  She has helped organizations and pharmaceutical companies commit to the elimination of racial and ethnic health disparities and adopt and implement diversity, equity, inclusion, and belonging practice by connecting with racially and ethnically diverse populations.  

When asked to comment about the low uptake of the vaccine among African Americans, Thorne stated, "The coronavirus has hit the African American, Latinx and Native American communities the hardest; however, they are deeply wary and mistrust the health care system. The implicit bias, systemic racism, and the historic mistreatment of people of color, even among the middle-class and insured, are causing hesitancy and concern.  Sadly, those who want the vaccine, especially in rural communities, are prevented access to appointments because of the digital divide." 

The HHS Office of Minority Health (OMH) has recognized that the COVID-19 pandemic has disproportionately impacted racial and ethnic minority communities. Therefore, for this year's National Minority Health Month, OHM theme #VaccineReady underscored these vulnerable communities need to get vaccinated as more vaccines become available.

Although Thorne is disappointed, saddened and disturbed by the low uptake of vaccines among people of color, she believes that the authorities have a responsibility to encourage this group to get inoculated. Thorne added, "Success COVID-19 vaccine outcomes will accrue only when state, municipalities, and healthcare organizations are comfortable with multiculturalism and take strategic, measurable, and sustainable action to partner with health advocates, non-profits, local businesses, and churches for effective targeted outreach."

Thorne's company, Multicultural Healthcare Marketing Group MHMG), offers cultural competency training and multicultural healthcare marketing for organizations that want to connect with minority groups. To learn more about Sheila Thorne and her work, visit https://sheilathorne.com.

Public Relations Contact: 

Candace Sandy

[email protected] 

Phone: 929.249.2265

SOURCE MHMG


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: